期刊文献+

糖耐康含药血清对高糖状态下大鼠肝细胞糖脂代谢的影响 被引量:1

Effects of Tnagnaikang-containing Serum on the Glucose and Lipid Metabolism of rat Liver Cells Cultured in High-glucose Medium
原文传递
导出
摘要 目的:研究糖耐康含药血清对高糖状态下大鼠肝细胞糖脂代谢的影响。方法:通过培养大鼠肝细胞,在高糖诱导肝细胞胰岛素抵抗状态下,给予高、中、低剂量的糖耐康含药血清共培养24h后,观察肝细胞增殖情况,用葡萄糖氧化酶法检测细胞的葡萄糖消耗量,培养基和肝细胞内TG含量,肝细胞糖原含量。结果:与正常组比较,高糖刺激下,肝细胞增殖显著受到抑制(P<0.01)、葡萄糖消耗量和糖原含量减少(P<0.01),TG含量增加(P<0.01);与高糖组比较,吡格列酮组与TNK各剂量上述情况有不用程度的改善,作用效果类似。结论:糖耐康含药血清具有改善高糖环境下肝脏糖脂代谢紊乱的作用,可能与增加肝细胞胰岛素敏感性改善IR有关。 Objective: To investigate the modulation of Tnagnaikang-containing serum (TNK) on glucose and lipid metabolism in rat liver cells pretreated with high glucose. Methods: Cultured rat liver cells induced by high glucose for insulin resistance, were co-cultured with different concentrations of TNK and Pioglitazone for 24 h. The cek-8 assay were observed and glucose consumptions, TG, and hepatic glycogen were measured. Results: 30 mmol/L glucose could induce remarkably proliferation, glucose consumptions, and hepatic glycogen of rat liver cells (P〈0.01), and increase TG of rat liver cells, comparison indicated notable difference with blank control group (P〈0.01), these can be improved to a certain extent after combination with TNK and Pioglitazone (P〈0.05). Conclusion: TNK can improve glucose metabolic disturbance induced by high glucose.
出处 《现代生物医学进展》 CAS 2013年第24期4630-4633,共4页 Progress in Modern Biomedicine
基金 教育部科学技术研究重大项目(2011-07) 北京中医药大学创新团队项目(2011-CXTD-19)
关键词 糖耐康 肝细胞 高糖 糖代谢 脂代谢 Tangnaikang Liver cells High-glucose medium Glucose metabolism Lipid metabolism
  • 相关文献

参考文献18

  • 1刘国萍,缪珩.肝脏胰岛素抵抗的分子机制[J].临床荟萃,2009,24(17):1561-1562. 被引量:7
  • 2牛洁,刘铜华,王志程,杨丽霞.糖耐康颗粒对胰岛素抵抗3T3–L1脂肪细胞炎症因子的影响[J].深圳中西医结合杂志,2009,19(2):65-68. 被引量:5
  • 3郭翔宇,段颖,李娟娥,杨丽霞,黄链莎,王志程,王贺瑶,刘铜华.糖耐康对肥胖Zucker大鼠血糖的影响及其机制(英文)[J].中西医结合学报,2010,8(6):535-540. 被引量:13
  • 4Seidell J C, Oosterlee A, Deurenberg P, et al. Abdominal fat depots measured with computed tomography: effects of degree of obesity, sex, and age[J]. Eur J Clin Nutr, 1988, 42(9): 805-815.
  • 5Resnick H E, Foster G L, Bardsley J, et al. Achievement of American Diabetes Association clinical practice recommendations among U. S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey[J]. Diabetes Care, 2006, 29(3): 531-537.
  • 6Jr. D'Agostino R B, Hamman R F, Karter A J, et al. Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study[J]. Diabetes Care, 2004, 27(9): 2234-2240.
  • 7丁秋瑾,刘康,刘保林.胰岛素抵抗细胞模型的研究进展[J].海峡药学,2011,23(7):4-7. 被引量:3
  • 8Malmstrom R, Packard C J, Caslake M, et al. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM[J]. Diabetol- ogia, 1997, 40(4): 454-462.
  • 9Fisher E A, Ginsberg H N. Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins [J]. J Biol Chem, 2002, 277(20): 17377-17380.
  • 10Dresner A, Laurent D, Marcucci M, et al. Effects of fi'ee fatty acids on glucose transport and IRS-l-associated phosphatidylinositol 3-kinase activity[J]. J Clin Invest, 1999, 103(2): 253-259.

二级参考文献80

共引文献39

同被引文献13

  • 1刘率男,申竹芳.糖尿病治疗新靶点糖原合成酶激酶-3抑制剂的研究进展[J].药学学报,2007,42(12):1227-1231. 被引量:12
  • 2Mussig K, Fiedler H, Staiger H, et al. Insulin-induced stimulation of JNK and the PI 3-kinase/mTOR pathway leads to phosphorylation of serine 318 of IRS-1 in C2C12 myotubes[ J ]. Biochem Biophys Res Commuuicat, 2005, 335(3) :819-825.
  • 3Lundgren M, Svensson M, Lindmark S, et al. Fat cell enlargement is an independent marker of insulin resistance and ' hyperleptinaemia' [ J ]. Diabetologia, 2007,50( 3 ) :625-633.
  • 4Choi KM, Kim YH, Kim NH, et al. Insulin resistence syndrome in elderly Koreans [ J ]. Diabetes, 2000, 49 (Suppll) : A1744-1747.
  • 5Jie WP, Xiang KS, Chen L, et al. Epidemiologic study on metabolic syndrome in normal and overweight Chinese in Shanghai [ J ]. Diabetes, 2000,49 ( Suppl 1 ) : A148.
  • 6Ferre T, Riu E, Franckhauser S, et al. Long term over expression of glucokinase in the liver if transgenic leads to insulin resistance [ J ]. Diabetologia, 2003, 46 ( 12 ) : 1662-1668.
  • 7Karlsson M, Thorn H, Parpal S, et al. Insulin induces translocation of glucose transporter GLUT4 to plasma membrane caveolae in adipocytes [ J ]. FASEB J, 2002,16 (2) :249-251.
  • 8王芬,何华亮,江南,贾淑明,刘铜华.糖耐康对自发性2型糖尿病KKAy小鼠胰岛素信号转导的影响[J].中国实验方剂学杂志,2008,14(1):46-49. 被引量:21
  • 9王志程,牛洁,杨丽霞,郭翔宇,刘铜华.中药复方糖耐康对糖尿病GK大鼠尿蛋白影响的实验研究[J].中国中医急症,2009,18(4):579-580. 被引量:8
  • 10郭翔宇,段颖,李娟娥,杨丽霞,黄链莎,王志程,王贺瑶,刘铜华.糖耐康对肥胖Zucker大鼠血糖的影响及其机制(英文)[J].中西医结合学报,2010,8(6):535-540. 被引量:13

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部